Rubinstein A, Gibson J C, Paterniti J R, Kakis G, Little A, Ginsberg H N, Brown W V
J Clin Invest. 1985 Feb;75(2):710-21. doi: 10.1172/JCI111751.
In normal subjects, apolipoprotein E (apo E) is present on very low density lipoproteins (VLDL) (fraction I) and on particles of a size intermediate between VLDL and low density lipoproteins (LDL) (fraction II). The major portion of apo E is, however, on particles smaller than LDL but larger than the average high density lipoproteins (HDL) (fraction III). To investigate the possible role of the vascular lipases in determining this distribution of apo E among the plasma lipoproteins, we studied subjects with primary deficiency of either hepatic lipase or of lipoprotein lipase and compared them with normal subjects. Subjects with familial hepatic triglyceride lipase deficiency (n = 2) differ markedly from normal in that fraction II is the dominant apo E-containing group of lipoproteins. When lipolysis of VLDL was enhanced in these subjects upon release of lipoprotein lipase by intravenous heparin, a shift of the apo E from VLDL into fractions II and III was observed. In contrast, apolipoproteins CII and CIII (apo CII and CIII, respectively) did not accumulate in intermediate-sized particles but were shifted markedly from triglyceride rich lipoproteins to HDL after treatment with heparin. In subjects with primary lipoprotein lipase deficiency (n = 4), apo E was confined to fractions I and III. Release of hepatic triglyceride lipase by heparin injection in these subjects produced a shift of apo E from fraction I to III with no significant increase in fraction II. This movement of apo E from large VLDL and chylomicron-sized particles occurred with little hydrolysis of triglyceride and no significant shift of apo CII or CIII into HDL from triglyceride rich lipoproteins. When both lipoprotein lipase and hepatic triglyceride lipase were released by intravenous heparin injection into normal subjects (n = 3), fraction I declined and the apo E content of fraction III increased by an equivalent amount. Either moderate or no change was noted in the intermediate sized particles (fraction II). These data strongly support the hypothesis that fraction II is the product of the action of lipoprotein lipase upon triglyceride rich lipoproteins and is highly dependent on hepatic triglyceride lipase for its further catabolism. In addition, the hydrolysis by hepatic triglyceride lipase of triglyceride rich lipoproteins in general results in a preferential loss of apo E and its transfer to a specific group of large HDL.
在正常受试者中,载脂蛋白E(apo E)存在于极低密度脂蛋白(VLDL)(组分I)以及大小介于VLDL和低密度脂蛋白(LDL)之间的颗粒上(组分II)。然而,apo E的主要部分存在于比LDL小但比平均高密度脂蛋白(HDL)大的颗粒上(组分III)。为了研究血管脂肪酶在决定apo E在血浆脂蛋白中这种分布的可能作用,我们研究了原发性肝脂肪酶或脂蛋白脂肪酶缺乏的受试者,并将他们与正常受试者进行比较。家族性肝甘油三酯脂肪酶缺乏的受试者(n = 2)与正常人有显著差异,因为组分II是含apo E的主要脂蛋白组。当通过静脉注射肝素释放脂蛋白脂肪酶使这些受试者的VLDL脂解增强时,观察到apo E从VLDL转移到组分II和III中。相反,载脂蛋白CII和CIII(分别为apo CII和CIII)没有在中等大小的颗粒中积累,而是在用肝素处理后从富含甘油三酯的脂蛋白显著转移到HDL。在原发性脂蛋白脂肪酶缺乏的受试者(n = 4)中,apo E局限于组分I和III。在这些受试者中通过注射肝素释放肝甘油三酯脂肪酶导致apo E从组分I转移到III,而组分II没有显著增加。apo E从大的VLDL和乳糜微粒大小的颗粒的这种转移伴随着很少的甘油三酯水解,并且没有apo CII或CIII从富含甘油三酯的脂蛋白显著转移到HDL。当通过静脉注射肝素同时释放脂蛋白脂肪酶和肝甘油三酯脂肪酶到正常受试者(n = 3)中时,组分I下降,组分III的apo E含量等量增加。中等大小颗粒(组分II)中观察到中度变化或无变化。这些数据有力地支持了以下假设:组分II是脂蛋白脂肪酶对富含甘油三酯的脂蛋白作用的产物,并且其进一步分解代谢高度依赖于肝甘油三酯脂肪酶。此外,肝甘油三酯脂肪酶对富含甘油三酯的脂蛋白的水解通常导致apo E的优先丢失及其转移到特定组的大HDL中。